[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Rulemaking History for OTC Antiemetic Drug Products
View by Topic

Final Monograph (21 CFR part 336):  
Antiemetic Drug Products for Over-the-Counter Human Use


Date Federal Register Citation Description

3/21/1975

40FR12902 PDF document

Advance Notice of Proposed Rulemaking

7/13/1979

44FR41064 PDF document

Tentative Final Monograph

10/26/1979

44FR61610 PDF document

Reopening of Administrative Record: Category II and III active ingredients

4/30/1987

52FR15886 PDF document

Final Monograph

9/15/1988

53FR35808 PDF document

Technical Amendment: Clarifies age range for children's dosage

8/26/1993

58FR45216 PDF document

Proposed Rule: Warnings related to age

4/11/1994

59FR16981 PDF document

Final Rule: Warnings related to age

8/29/1997

62FR45767 PDF document
[HTML]

Proposed Rule: Requires warnings for diphenhydramine

12/6/2002

67FR72555 PDF document
[HTML]

Final Rule: Requires warnings for diphenhydramine

PDF document PDF requires the free Adobe Acrobat Reader

top arrow Back to Top     back arrow Back to Rulemaking Index

Date updated: May 8, 2007

horizonal rule